Home
Barnatoret
Pharma - lista elektronike
Twitter
Farmakovigjilencë
Meny kryesore
Home
Pharmaks Agency
Lajme
Blog
Kontakti
Kërkim
Feeds lajmesh
PharmINDEX 2009
Newsletters-Regjistrimi
Administrator
Propecia
Viagra Professional
Cialis Professional
Viagra Super Active
Cialis Super Active
Viagra Soft Tabs
Cialis Oral Jelly
Seroquel (Quetiapine)
Prednisone (Deltasone)
Cialis Soft Tabs
Viagra Oral Jelly
Neurontin (Gabapentin)
Careprost (Generic Latisse)
Accutane (Isotretinoin)
Antabuse (Disulfiram)
Paxil (Paroxetine)
Prozac (Fluoxetine)
Cafergot (Caffeine)
Augmentin (Amoxicillin)
Zovirax (Acyclovir)
Arkiva
Dhetor, 2010
Shtator, 2010
Maj, 2010
Mars, 2010
Shkurt, 2010
Dhetor, 2009
Nandor, 2009
Tetor, 2009
Shtator, 2009
Gusht, 2009
Sekcionet
Lajme
Flash lajme
K2 Tools
Nëntor 2011 (5)
Shtator 2011 (3)
Korrik 2011 (5)
Maj 2011 (3)
Mars 2011 (1)
Shkurt 2011 (1)
Janar 2011 (2)
Dhjetor 2010 (1)
Nëntor 2010 (1)
Shtator 2010 (2)
Maj 2010 (3)
Prill 2010 (6)
Home
Feeds lajmesh
FDA What's New Drugs
FDA What's New Drugs
What's New: Drugs RSS Feed
FDA Drug Safety Communication: Planned return of CardioGen-82 to market with new Boxed Warning
Current Drug Shortages
New and Generic Drug Approvals
Clinical Investigator Inspection List (CLIIL)
Newly Added Guidance Documents
Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva (PML por sus siglas en inglés) relacionado con Tysabri (natalizumab)
Initiative Partners
Resources and Tools for Preventing Surgical Fires
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
Generic Drugs: Information for Industry
Feeds lajmesh FDA What's New Drugs
Feeds lajmesh FDA What's New Drugs
Feeds lajmesh FDA What's New Drugs